Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery
Launched by HOSPITAL UNIVERSITARIO SAN IGNACIO · Apr 21, 2025
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Patients using the Minimed 780G device who completed training and clinical follow-up in the Endocrinology Unit of San Ignacio University Hospital. Through the clinical follow-up established by the unit, patients must inform their physicians if they will be undergoing elective surgery or contact the medical team if they require emergency surgery during the recruitment period.
Data Collection Prior to the Surgical Procedure Once enrolled in the study, information about the surgical procedure will be collected, including the type of procedure and approximate duration. Patients will then be as...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:Patients older than 18 years AHCL (Minimed 780G) users undergoing elective and urgent surgery during the study period.
- Exclusion Criteria:
- • Patients whose pump use was discontinued during the perioperative period. Pregnant patients. Patients without sensor data in the 2 weeks before and after surgery.
About Hospital Universitario San Ignacio
Hospital Universitario San Ignacio is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution within the region, it combines state-of-the-art facilities with a commitment to patient-centered care and medical education. The hospital collaborates with multidisciplinary teams to conduct rigorous clinical studies aimed at improving treatment outcomes and enhancing the understanding of various health conditions. With a focus on ethical practices and regulatory compliance, Hospital Universitario San Ignacio strives to contribute significantly to the advancement of medical science and the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bogota, Cundinamarca, Colombia
Patients applied
Trial Officials
Ana M Gómez Medina, Endocrinologyst
Principal Investigator
Hospital Universitario San Ignacio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported